Skip to main content
. 2021 Feb 8;10:610820. doi: 10.3389/fonc.2020.610820

Figure 2.

Figure 2

The frequency of TP53 mutations in de novo AML; mutations in AML from the TCGA study (11) are shown in this figure. Only the 25 most frequent mutations are represented.